To what extent are psychiatrists aware of the comorbid somatic illnesses of their patients with serious mental illnesses? – a cross-sectional secondary data analysis-Reference-Cited by-同舟云学术

To what extent are psychiatrists aware of the comorbid somatic illnesses of their patients with serious mental illnesses? – a cross-sectional secondary data analysis

Published:2017-02-23 Issue:1 Volume:17 Page:
ISSN:1472-6963
Container-title:BMC Health Services Research
language:en
Short-container-title:BMC Health Serv Res

Author:

Dornquast Christina,Tomzik Juliane,Reinhold Thomas,Walle Matthias,Mönter Norbert,Berghöfer Anne

Publisher

Springer Science and Business Media LLC

Subject

Health Policy

Link

http://link.springer.com/content/pdf/10.1186/s12913-017-2106-6.pdf

Reference32 articles.

1. Baumeister H, Härter M. Körperliche Beschwerden bei Patienten mit psychischen Störungen. Z Psychiatr Psychol Psychother. 2007;55(1):9–19.

2. Wells KB, Golding JM, Burnam MA. Affective, substance use, and anxiety disorders in persons with arthritis, diabetes, heart disease, high blood pressure, or chronic lung conditions. Gen Hosp Psychiatry. 1989;11(5):320–7.

3. Wells KB, Golding JM, Burnam MA. Chronic medical conditions in a sample of the general population with anxiety, affective, and substance use disorders. Am J Psychiatr. 1989;146(11):1440–6.

4. Hewer W, Füeßl H. Körperliche Erkrankungen bei psychiatrischen Patienten–Teil I. Fortschritte der Neurologie·. Psychiatrie. 2009;77(12):720–37.

5. Horvitz-Lennon M, Kilbourne AM, Pincus HA. From silos to bridges: meeting the general health care needs of adults with severe mental illnesses. Health Aff. 2006;25(3):659–69.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A network of transcriptomic signatures identifies novel comorbidity mechanisms between schizophrenia and somatic disorders;Discover Mental Health;2024-04-04

2. How Do Mental Disorders and Combinations of Disorders Affect the Odds of Injuries and Poisoning?;Journal of Nervous & Mental Disease;2024-03-21

3. Targeting NMDAR/AMPAR: a promising pharmacotherapeutic approach for depressive disorders;S.S. Korsakov Journal of Neurology and Psychiatry;2024

4. A network of transcriptomic signatures identifies novel comorbidity mechanisms between schizophrenia and somatic disorders;2023-10-03

5. Claims data analysis of the health care utilization for patients with coronary heart disease and mental comorbidity;Journal of Psychosomatic Research;2023-09